416 related articles for article (PubMed ID: 25213318)
1. Trends in use of psychotropic medications among patients treated with cholinesterase inhibitors in Japan from 2002 to 2010.
Okumura Y; Togo T; Fujita J
Int Psychogeriatr; 2015 Mar; 27(3):407-15. PubMed ID: 25213318
[TBL] [Abstract][Full Text] [Related]
2. National trends in psychotropic medication polypharmacy in office-based psychiatry.
Mojtabai R; Olfson M
Arch Gen Psychiatry; 2010 Jan; 67(1):26-36. PubMed ID: 20048220
[TBL] [Abstract][Full Text] [Related]
3. Psychotropic drug use in older people with mental illness with particular reference to antipsychotics: a systematic study of tolerability and use in different diagnostic groups.
Curran S; Turner D; Musa S; Wattis J
Int J Geriatr Psychiatry; 2005 Sep; 20(9):842-7. PubMed ID: 16116576
[TBL] [Abstract][Full Text] [Related]
4. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
5. Psychotropic use and associated neuropsychiatric symptoms among patients with dementia in the USA.
Maust DT; Langa KM; Blow FC; Kales HC
Int J Geriatr Psychiatry; 2017 Feb; 32(2):164-174. PubMed ID: 26889640
[TBL] [Abstract][Full Text] [Related]
6. Psychotropic and cognitive-enhancing medication use and its documentation in contemporary long-term care practice.
Rojas-Fernandez C; Mikhail M; Brown SG
Ann Pharmacother; 2014 Apr; 48(4):438-46. PubMed ID: 24473493
[TBL] [Abstract][Full Text] [Related]
7. Time trends in antipsychotic drug use in patients with dementia: a nationwide study.
Nørgaard A; Jensen-Dahm C; Gasse C; Hansen HV; Waldemar G
J Alzheimers Dis; 2016; 49(1):211-20. PubMed ID: 26444790
[TBL] [Abstract][Full Text] [Related]
8. Trends in psychotropic drug prescribing in Norwegian nursing homes from 1997 to 2009: a comparison of six cohorts.
Ruths S; Sørensen PH; Kirkevold Ø; Husebø BS; Krüger K; Halvorsen KH; Selbaek G
Int J Geriatr Psychiatry; 2013 Aug; 28(8):868-76. PubMed ID: 23147389
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and correlates of psychotropic drug use in Dutch nursing-home patients with dementia.
Nijk RM; Zuidema SU; Koopmans RT
Int Psychogeriatr; 2009 Jun; 21(3):485-93. PubMed ID: 19368752
[TBL] [Abstract][Full Text] [Related]
10. Psychotropic and anti-dementia treatment in elderly persons with clinical signs of dementia with Lewy bodies: a cross-sectional study in 40 nursing homes in Sweden.
Zahirovic I; Torisson G; Wattmo C; Londos E
BMC Geriatr; 2018 Feb; 18(1):50. PubMed ID: 29454305
[TBL] [Abstract][Full Text] [Related]
11. Mortality risk in patients with dementia treated with antipsychotics versus other psychiatric medications.
Kales HC; Valenstein M; Kim HM; McCarthy JF; Ganoczy D; Cunningham F; Blow FC
Am J Psychiatry; 2007 Oct; 164(10):1568-76; quiz 1623. PubMed ID: 17898349
[TBL] [Abstract][Full Text] [Related]
12. The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary.
Alexopoulos GS; Jeste DV; Chung H; Carpenter D; Ross R; Docherty JP
Postgrad Med; 2005 Jan; Spec No():6-22. PubMed ID: 17203561
[TBL] [Abstract][Full Text] [Related]
13. Trends in prescription of psychotropic medications to children and adolescents in Australian primary care from 2011 to 2018.
Klau J; Bernardo CO; Gonzalez-Chica DA; Raven M; Jureidini J
Aust N Z J Psychiatry; 2022 Nov; 56(11):1477-1490. PubMed ID: 34963342
[TBL] [Abstract][Full Text] [Related]
14. Geriatric psychopharmacology.
Salzman C
Annu Rev Med; 1985; 36():217-28. PubMed ID: 2859829
[TBL] [Abstract][Full Text] [Related]
15. Trends in antipsychotic prescriptions for Japanese outpatients during 2006-2012: a descriptive epidemiological study.
Kochi K; Sato I; Nishiyama C; Tanaka-Mizuno S; Doi Y; Arai M; Fujii Y; Matsunaga T; Ogawa Y; Furukawa TA; Kawakami K
Pharmacoepidemiol Drug Saf; 2017 Jun; 26(6):642-656. PubMed ID: 28266090
[TBL] [Abstract][Full Text] [Related]
16. Association of the Centers for Medicare & Medicaid Services' National Partnership to Improve Dementia Care With the Use of Antipsychotics and Other Psychotropics in Long-term Care in the United States From 2009 to 2014.
Maust DT; Kim HM; Chiang C; Kales HC
JAMA Intern Med; 2018 May; 178(5):640-647. PubMed ID: 29550856
[TBL] [Abstract][Full Text] [Related]
17. Psychotropic medication prescribing in assisted living and nursing home residents with dementia after the National Partnership.
Coe AB; Zhang T; Zullo AR; Gerlach LB; Thomas KS; Daiello LA; Varma H; Lo D; Joshi R; Shireman TI; Bynum JPW
J Am Geriatr Soc; 2022 Dec; 70(12):3513-3525. PubMed ID: 35984088
[TBL] [Abstract][Full Text] [Related]
18. Psychotropic medication use and cognition in institutionalized older adults with mild to moderate dementia.
Eggermont LH; de Vries K; Scherder EJ
Int Psychogeriatr; 2009 Apr; 21(2):286-94. PubMed ID: 19243660
[TBL] [Abstract][Full Text] [Related]
19. Alternatives to atypical antipsychotics for the management of dementia-related agitation.
Passmore MJ; Gardner DM; Polak Y; Rabheru K
Drugs Aging; 2008; 25(5):381-98. PubMed ID: 18447403
[TBL] [Abstract][Full Text] [Related]
20. Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour.
Deb S; Unwin G; Deb T
J Intellect Disabil Res; 2015 Jan; 59(1):11-25. PubMed ID: 24450426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
